Richter said that the applications include all indications covered by the reference products Prolia and Xgeva.
Denosumab is indicated for treating osteoporosis in postmenopausal women, preventing skeletal-related complications in cancers that have spread to the bone.
It is also used in treating unresectable giant cell tumors of the bone that cannot be entirely removed through surgery.
Producing journalism that is worthy of the name is a costly business. For over 30 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.
